Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) Short Interest Update

Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) was the recipient of a significant drop in short interest in the month of July. As of July 15th, there was short interest totaling 4,306 shares, a drop of 85.6% from the June 30th total of 29,843 shares. Currently, 0.4% of the company’s stock are short sold. Based on an average daily volume of 11,693 shares, the short-interest ratio is presently 0.4 days.

Virtus LifeSci Biotech Products ETF Trading Down 0.9%

BBP traded down $0.87 on Friday, hitting $96.39. 1,927 shares of the company were exchanged, compared to its average volume of 8,109. Virtus LifeSci Biotech Products ETF has a twelve month low of $60.91 and a twelve month high of $105.21. The firm has a 50-day moving average price of $91.90 and a two-hundred day moving average price of $86.41.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in BBP. Prime Capital Investment Advisors LLC purchased a new position in Virtus LifeSci Biotech Products ETF during the fourth quarter worth about $1,896,000. Flow Traders U.S. LLC purchased a new stake in Virtus LifeSci Biotech Products ETF in the 2nd quarter valued at approximately $431,000. Finally, Comprehensive Financial Planning Inc. PA purchased a new stake in Virtus LifeSci Biotech Products ETF in the 4th quarter valued at approximately $557,000.

About Virtus LifeSci Biotech Products ETF

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.